<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 1, 1997
ENCORE MEDICAL CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware 65-0572565
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
9800 Metric Boulevard
Austin, Texas 78758
(Address of principal executive offices) (Zip code)
512-832-9500
(Registrant's telephone number including area code)
Not applicable
(Former name and former address, if changed since last report)
<PAGE> 2
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
Effective May 1, 1997, Encore Medical Corporation (the "Company")
engaged Price Waterhouse, L.L.P. to be its principal accountant. Formerly,
Richard A. Eisner & Co. had been the principal accountant of the Company. This
change was made as a result of the merger between Healthcare Acquisition, Inc.,
a wholly-owned subsidiary of the Company, and Encore Orthopedics, Inc.
("Encore"). Price Waterhouse LLP has been the principal accountant for Encore
since April 1, 1992.
Price Waterhouse LLP had not been consulted by the Company during
the Company's two most recent fiscal years and any subsequent interim
period prior to engaging Price Waterhouse LLP
ITEM 7. EXHIBITS
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
ENCORE MEDICAL CORPORATION
By: /s/ NICK CINDRICH
May 30, 1997 ---------------------------------------
- ---------------------- Nick Cindrich, Chairman of the Board
Date and Chief Executive Officer
